Sp. Jaw et al., CHRONIC TREATMENTS WITH 5-HT1A AGONISTS ATTENUATE POSTHYPOXIC MYOCLONUS IN RATS, Pharmacology, biochemistry and behavior, 52(3), 1995, pp. 577-580
Following 10 min cardiac arrest and resuscitation, male Sprague-Dawley
rats developed posthypoxic myoclonus. This phenomenon peaked at 14 da
ys and disappeared by 60 days after cardiac arrest. From previous resu
lts, the 5-hydroxytryptamine (5-HT) system was implicated in the patho
genesis of the disease. In the present study, we investigated the invo
lvement of 5-HT1A receptors in posthypoxic myoclonus in rats. Single i
njections of 5-HT1A agonists, buspirone (5 and 10 mg/kg body wt.) or 8
-OH-DPAT (1, 2, and 4 mg/kg), had no effect on either the intensity or
time course of the disease. In contrast, multiple injections (twice a
day for 7 or more days) of buspirone (10 mg/kg) or 8-OH-DPAT (4 mg/kg
) significantly attenuated the myoclonus scores of animals (p < 0.05).
The results indicate that chronic stimulation of 5-HT1A receptors in
the brain may accelerate endogenous compensatory mechanisms and shorte
n the time course of the disease.